Evidence map›Paper›PMID 32202535›Full record

ReviewPathologica2020

The broad landscape of follicular lymphoma: Part II.

Stefano Fratoni, Magda Zanelli, Maurizio Zizzo, Francesca Sanguedolce, Valentina Aimola, Giulia Cerrone, Linda Ricci, Alessandra Filosa, Giovanni Martino, Antonella Maria Fara and 3 more

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Stefano FratoniDepartment of Anatomic Pathology, St. Eugenio Hospital of Rome, Rome, Italy.
Magda ZanelliPathology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Maurizio ZizzoSurgical Oncology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Francesca SanguedolcePathology Unit, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Foggia, Foggia, Italy.
Valentina AimolaPathology Unit, University of Cagliari, Cagliari, Italy.
Giulia CerronePathology Unit, University of Cagliari, Cagliari, Italy.
Linda RicciPathology Unit, University of Siena, Siena, Italy.
Alessandra FilosaPathology Unit, Ospedale di Ascoli Piceno, Ascoli, Italy.
Giovanni MartinoHematology Unit, CREO, Azienda Ospedaliera di Perugia, University of Perugia, Perugia, Italy.
Antonella Maria FaraPathology Unit, Department of Medical, Surgical and Experimental Surgery, University of Sassari, Italy.
Valerio AnnessiGeneral Surgery Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Guastalla, Reggio Emilia, Italy.
Alessandra SorianoGastroenterology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Stefano AscaniPathology Unit, Azienda Ospedaliera Santa Maria Terni, University of Perugia, Terni, Italy.
St. Eugenio Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular lymphoma is a neoplasm derived from follicle center B cells, typically both centrocytes and centroblasts, in variable proportions according to the lymphoma grading. The pattern of growth may be entirely follicular, follicular and diffuse and rarely completely diffuse. It represents the second most common non-Hodgkin lymphoma, after diffuse large B-cell lymphoma and it is the most common low-grade mature B-cell lymphoma in Western countries. In the majority of cases, follicular lymphoma is a nodal tumor, occurring in adults and is frequently associated with the translocation t(14;18)(q32;q21)/IGH-BCL2. However, in recent years the spectrum of follicular lymphoma has expanded and small subsets of follicular lymphoma, which differ from common follicular lymphoma, have been identified and included in the current 2017 WHO classification. The aim of our review is to describe the broad spectrum of follicular lymphoma, pointing out that the identification of distinct clinicopathological variants of follicular lymphoma is relevant for the patient outcomes and treatment.

Indexed as

Biomarkers, TumorHumansIn Situ Hybridization, FluorescenceLymphoma, FollicularLymphoma, Large B-Cell, DiffuseTranslocation, GeneticBiomarkers, TumorB-cellcentroblastcentrocytefollicular lymphoma

Identifiers

PMID32202535
PMCPMC7931560
OpenAlexW3005250590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.